Amentoflavone Inhibits Experimental Tumor Metastasis Through a Regulatory Mechanism Involving MMP-2, MMP-9, Prolyl Hydroxylase, Lysyl Oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and Cytokines in Lung Tissues of C57BL/6 Mice

REFERENCES

• I.J. Fidler, D.M. Gersten, and I.R. Hart. 1979. The biology of cancer invasion and metastasis. Adv. Cancer Res. 28:149–250.
   Google Scholar
• P.S. Steeg, G. Bevilacqua, L. Kopper, U.P. Thorgeirsson, J.B. Talmadge, L.A. Liotta, and M.E. Sobel. 1988. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 24:200–204.
   Google Scholar
• M.T. Hartsough, S.E. Clare, M. Mair, A.G. Elkahloun, D. Sgroi, C.K. Osborne, G. Clark, and P.S. Steeg. 2001. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res. 61:2320–2327.
   PubMed Web of Science ®Google Scholar
• Y. Takahashi, S. Takahashi, Y. Shiga, T. Yoshimi, and T. Miura. 2000. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J. Biol. Chem. 275:14139–14146.
   PubMed Web of Science ®Google Scholar
• D.A. Kirschmann, E.A. Seftor, S.F. Fong, D.R. Nieva, C.M. Sullivan, E.M. Edwards, P. Sommer, K. Csiszar, and M.J. Hendrix. 2002. A molecular role of lysyl oxidase in breast cancer invasion. Cancer Res. 62:4478–4483.
   PubMed Web of Science ®Google Scholar
• J.S. Sebolt-Leopold, D.T. Dudley, R. Herrara, K. Van Becelaera, A. Wiland, R.C. Gowan, H. Tecle, S.D. Barrett, A. Bridges, S. Przybranowski, W.R. Leopold, and A.R. Saltiel. 1999. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Med. 5:810–816.
   PubMed Web of Science ®Google Scholar
• S. Huang, C.D. Bucana, M. Van Arsdall, and I.J. Fidler. 2002. Stat 1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 21:2504–2512.
   PubMed Web of Science ®Google Scholar
• H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler. 1993. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med 4:197–250.
   PubMedGoogle Scholar
• V.M. Kahari, and U. Saarialho-Kere. 1999. Matrix metalloproteinases and their inhibitors in tumor growth and invasion. Ann. Med. 31:34–45.
   PubMed Web of Science ®Google Scholar
• P. Salven, H. Manpaa, A. Orpana, K. Alitalo, and H. Joensuu. 1997. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin. Cancer Res. 3:647–651.
   PubMed Web of Science ®Google Scholar
• G. Fontanini, S. Vignati, L. Boldrini, S. Chine, V. Silvestri, M. Lucchi, A. Mussi, C.A. Angeletti, and G. Bevilacqua. 1997. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res. 3:861–865.
   PubMed Web of Science ®Google Scholar
• G. Dong, Z. Chen, T. Kato, and C. Van Waes. 1999. The host environment promotes the constitutive activation of nuclear factor-kappa B and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res. 59:3495–3504.
   PubMed Web of Science ®Google Scholar
• N.B. Liabakk, I. Talbot, R.A. Smith, K. Wilkinson, and F. Balkwill. 1996. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56:190–196.
   PubMed Web of Science ®Google Scholar
• S.D. Shapiro. 1998. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 10:602–608.
   PubMed Web of Science ®Google Scholar
• E. Middleton, C. Kandaswami, and T.C. Theoharides. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52:673–751.
   PubMed Web of Science ®Google Scholar
• G. Di Carlo, N. Mascolo, A.A. Izzo, and F. Capasso. 1999. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci. 4:337–353.
   Google Scholar
• A.L. Miller. 1996. Antioxidant flavonoids: Structure, functions and clinical usage. Alt. Med. Rev. 1:103–111.
   Google Scholar
• T. Khan, and S. Sultana. 2006. Apigenin induces apoptosis in Hep G2 cells: Possible role of TNF-α and IFN-γ. Toxicology 217:206–212.
   PubMed Web of Science ®Google Scholar
• C. Guruvayoorappan, and G. Kuttan. 2008. Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc.) 73 (2):209–218.
   PubMedGoogle Scholar
• C. Guruvayoorappan, and G. Kuttan. 2007. Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Integr. Cancer Ther. 6:185–197.
   PubMed Web of Science ®Google Scholar
• T. Banerjee, A. Van der Vilet, and V.A. Ziboh. 2002. Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line. Prostaglandins Leukot Essent Fatty Acids 66:485–492.
   PubMed Web of Science ®Google Scholar
• D. Li, G.L. Graef, J.A. Yee, and L. Yan. 2004. Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice. J. Nutr. 134:1536–1540.
   PubMed Web of Science ®Google Scholar
• F. Bucar, S.M. Jachak, Y. Noreen, T. Kartnig, P. Perera, L. Bohlin, and M. Schubert-Zsilavecz. 1998. Amentoflavone from Biophytum sensitivum and its effect on COX-1/COX-2 catalysed prostaglandin biosynthesis. Planta Med. 64:373–374.
   PubMedGoogle Scholar
• D. Li, J.A. Yee, M.H. McGuire, P.A. Murphy, and L. Yan. 1999. Soybean isoflavones reduce experimental metastasis in mice. J. Nutr 129:1075–1078.
   PubMed Web of Science ®Google Scholar
• S.P. Cole. 1986. Rapid chemosensitivity testing of human lung tumor cells using MTT assay. Cancer Chemother. Pharmacol. 17:259–263.
   PubMed Web of Science ®Google Scholar
• A. Albini, H.K. Iwamoto, G.R. Kleinman, and et al 1987. A rapid in vitro assay quantitating the invasive potential of tumor cells. Cancer Res. 47:3239–3245.
   PubMed Web of Science ®Google Scholar
• K.H. Plate, G. Breier, H.A. Welch, and W. Risau. 1992. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845–848.
   PubMed Web of Science ®Google Scholar
• A.F. Chambers, and L.M. Matrisian. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1260–1270.
   PubMed Web of Science ®Google Scholar
• M.K. Gupta, and R.Y. Qin. 2003. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9:1144–1155.
   PubMed Web of Science ®Google Scholar
• G. Akiri, E. Sabo, H. Dafni, Z. Vadasz, Y. Kartvelishvily, N. Gan, O. Kessler, T. Cohen, M. Resnick, M. Neeman, and G. Neufeld. 2003. Lysyl oxidase protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res. 63:1657–1666.
   PubMed Web of Science ®Google Scholar
• J. Myllyharju. 2003. Prolyl 4-hydroxylase, the key enzymes of collagen biosynthesis. Matrix Biol. 22:15–24.
   PubMed Web of Science ®Google Scholar
• M.V. Panchenko, W.G. Stetler-Stevenson, O.V. Trubetskoy, S.N. Gacheru, and H.M. Kagan. 1996. Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J. Biol. Chem. 271:7113–7119.
   PubMed Web of Science ®Google Scholar
• M. Fahling, A. Perlewitz, A. Doller, and B.J. Thiele. 2004. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. Comp. Biochem. Physiol. Part C. 139:119–126.
   PubMed Web of Science ®Google Scholar
• M.W. Saif. 2006. Anti-angiogenesis therapy in pancreatic carcinoma. JOP. 7 (2):163–173.
   PubMedGoogle Scholar
• T.S. Lewis, P.S. Shapiro, and N.G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• G. Pearson, F. Robinson, T.B. Gibson, B.E. Xu, M. Karandikar, K. Berman, and M.H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 22:153–183. 2001
   PubMed Web of Science ®Google Scholar
• M. Knockaert, P. Lenormand, G. Baffet, N. Gray, P. Schultz, J. Pouyssegur, and L. Meijer. 2002. Oncogene 21:6413–6424.
   PubMed Web of Science ®Google Scholar
• Y.E. Chin, M. Kitagawa, K. Kuida, R.A. Flavell, and X.Y. Fu. 1997. Activation of STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 9:5328–5337.
   Google Scholar
• Y. Fujimoto, T. Ohtake, H. Nishimori, K. Ikuta, M. Ohhira, M. Ono, and Y. Kohgo. 1998. Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines. J. Gastroenterol. 33:368–375.
   PubMedGoogle Scholar
• N. Iizuka, M. Oka, T. Noma, A. Nakazawa, K. Hirose, and T. Suzuki. 1995. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res. 55:652–657.
   PubMed Web of Science ®Google Scholar
• S. Alex, B. Panikkar, C. Devi, and P. Balaram. 2002. Expression of nm23-H1 protein in relation to myometrial invasion in complete hydatidiform moles. J. Soc. Gynecol. Invest. 9:111–115.
   PubMedGoogle Scholar
• E. Lazar-Moinar, S. Toth, and A. Falus. 2000. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547–554.
   PubMedGoogle Scholar
• G. Dong, Z. Chen, T. Kato, and C. Van Waes. 1999. The host environment promotes the constitutive activation of nuclear factor-kappa B and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res. 59:3495–3504.
   PubMed Web of Science ®Google Scholar
• A. Naldini, and F. Carraro. 2005. Role of inflammatory mediators in angiogenesis. Curr. Drug Targ. 4:3–8.
   Google Scholar
• J.A. Sparano, P. Bernardo, P. Stephenson, W.J. Gradishar, J.N. Ingle, S. Zucker, and N.E. Davidson. 2004. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. J. Clin. Oncol. 22 (23):4683–4690.
   PubMedGoogle Scholar